Shares of Amarillo Biosciences, Inc. (OTCMKTS:AMAR – Get Free Report) dropped 14.3% during mid-day trading on Monday . The stock traded as low as $0.60 and last traded at $0.60. Approximately 6,100 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 18,253 shares. The stock had previously closed at $0.70.
Amarillo Biosciences Stock Down 14.3 %
The stock has a 50 day moving average of $0.60.
Amarillo Biosciences Company Profile
Amarillo Biosciences, Inc, a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases.
Read More
- Five stocks we like better than Amarillo Biosciences
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Business Services Stocks Investing
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to Use the MarketBeat Excel Dividend Calculator
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Amarillo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarillo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.